Interferon gamma 1a biosimilar - Shionogi

Drug Profile

Interferon gamma 1a biosimilar - Shionogi

Alternative Names: Imunomax; Imunomax-γ; S-6810

Latest Information Update: 22 Dec 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Shionogi
  • Class Antineoplastics; Antivirals; Interferons; Lymphokines
  • Mechanism of Action Interferon stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Mycosis fungoides
  • New Molecular Entity No

Highest Development Phases

  • Marketed Mycosis fungoides; Sezary syndrome

Most Recent Events

  • 01 Jun 2014 Launched for Mycosis fungoides and Sezary syndrome in Japan (IV)
  • 01 May 2014 Registered for Mycosis fungoides and Sezary syndrome in Japan (IV)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top